CompoAtlas

EUPHYTOSENUIT

Food supplement declared in France, declaration No 2016-12-124, decision dated 6 December 2016

EUPHYTOSENUIT (EUPHYTOSENUIT) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
EUPHYTOSENUIT
Food business operator placing the product on the market
BAYER HEALTHCARE SAS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Comprimé
Daily dose
1
Directions for use
un comprimé par jour, à prendre entre 30 mn et 1 heure avant le coucher
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil

Declaration 266363, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Passiflora incarnata L.Parties aériennesAutre extrait sec500 mg

Other active ingredients

NamePer day
Mélatoninenot declared

Additives

E460, E464, E570, E341, E468, E471

Other ingredients

Spirulina platensis (Gomont) Geitler

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : EUPHYTOSENUIT

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line